Petros Grivas on Twitter
We need prospective validation of these very interesting data on putative biomarkers associated with response & survival with EV therapy
Related Articles
John Launer: Learning from appraisals
I’ve been a GP appraiser for around 20 years, more or less since appraisals were introduced. I’ve appraised colleagues across the professional spectrum, from those…
Vision Impairment and Psychosocial Function in US Adults
This cross-sectional study evaluates associations between vision impairment and psychosocial outcomes in US adults.
Highlights From the American College of Cardiology’s 2024 Scientific Session
Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with…
Highlights From the American College of Cardiology’s 2024 Scientific Session
Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with…
The couple who carved out a place for teenagers with cancer
Myrna and Adrian Whiteson have won The Times/Sternberg Active Life award for their work with the Teenage Cancer Trust
Childhood and adolescence outcomes in offspring to parents with bipolar disorder: the impact of lifetime parental comorbidity, parental sex, and bipolar subtype
Background Offspring of parents with bipolar disorder have increased risks of their own psychopathology. However, a large-scale survey of psychiatric, somatic, and adverse social outcomes…
Pre-conferences | AIDS 2024 | International AIDS Society (IAS)
PrEP choices, community-led monitoring and differentiated service delivery beyond HIV treatment HIV cure research and vaccine research Understanding the needs of children and adolescents with…
Is Saw Palmetto Effective?
Saw palmetto has been used to treat prostate issues and other health concerns for thousands of years. Newer research suggests it’s not delivering the benefits…
Mass General Brigham is ready to move on without Dana-Farber, CEO says
The CEO of Mass General Brigham: “Does the Farber departure change things? Absolutely. I would say, however, our commitment remains to patients. We’re going to…
